Skip to content

Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO)

Can the Use of a Next Generation Partograph Based on WHO's Latest Intrapartum Care Recommendations Improve Neonatal Outcomes? a Stepped-wedge Cluster Randomized Trial (PICRINO)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05560802
Enrollment
120000
Registered
2022-09-29
Start date
2023-11-15
Completion date
2027-09-30
Last updated
2024-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor (Obstetrics)--Complications, Neonatal Complication

Keywords

neonatal outcomes, obstetric outcomes, labour care guide

Brief summary

The overall aim is to evaluate the impact of the use of two different guidelines for monitoring labor progress, the WHOs LCG versus standard care, on neonatal and maternal outcomes. The hypothesis is that the use of LCG will reduce adverse neonatal outcomes and decrease the number of intrapartum Cesarean sections compared with standard care. Secondly, other perinatal interventions and complications will be compared between the LCG and standard care groups, as well as economic considerations. This will be investigated using a multicenter, stepped-wedge cluster randomized trial design. In addition, the project will explore a series of quantitative and qualitative research questions to gain in-depth knowledge about experiences and perceptions about childbirth and the use of LCG. These research questions will be investigated using questionnaires, focus group and individual interviews with providers, partners and women that have gone through childbirth.

Detailed description

Study Title Can the use of a next generation partograph based on WHO's latest intrapartum care recommendations improve neonatal outcomes? A stepped-wedge cluster randomized trial (PICRINO). Primary Objectives To compare two different guidelines for monitoring labor progress, the the World Health Organization (WHO)'s Labour Care Guide (LCG) with standard care, and evaluate: Adverse neonatal outcome, a composite outcome of perinatal mortality and neonatal morbidity. Neonatal morbidity will include five-minute Apgar score \<7, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures, meconium aspiration syndrome, and admission to a neonatal unit. The rate of intrapartum cesarean section. Secondary Objectives Secondary outcomes will be a composite of severe neonatal outcomes including five-minute Apgar score \<4, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures and meconium aspiration syndrome and other relevant neonatal outcomes. Obstetric outcomes will be mode of delivery, oxytocin use, postpartum hemorrhage, perineal laceration (grade II-IV), duration of labor, women´s and partner´s experiences of childbirth, healthcare providers experiences of and compliance to LCG and economic considerations. Study Design A multicenter, stepped-wedge cluster randomized trial. Study Population All women in active labor at participating delivery units in Sweden. Power analysis With significance level 0.05, the power to detect the anticipated risk reduction (20%) would be \>0.999. Study Duration 2023-2025

Interventions

OTHERWHOs Labour care guide

Guidelines for monitoring labor progress, the WHOs LCG

Sponsors

The Swedish Research Council
CollaboratorOTHER_GOV
Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

multicenter, stepped-wedge cluster randomized trial

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

-All women in active labor

Exclusion criteria

-No

Design outcomes

Primary

MeasureTime frameDescription
Adverse neonatal outcome12 weeks up to 18 monthsa composite outcome of perinatal mortality and neonatal morbidity. Neonatal morbidity will include five-minute Apgar score \<7, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures, meconium aspiration syndrome, and admission to a neonatal unit.
The rate of intrapartum cesarean section12 weeks up to 18 monthsThe rate of intrapartum cesarean section

Secondary

MeasureTime frameDescription
Childbirth experience (women and partners)12 weeks up to 18 monthsinterviews questionaries
Neonatal outcomes12 weeks up to 18 monthsFive-minute Apgar score \<7 admission to neonatal unit Hypoxic ischemic encephalopathy II-III Intracranial hemorrhage Neonatal seizures Meconium aspiration syndrome Five-minute Apgar score \<4 Perinatal mortality neonatal mortality Neonatal infection Neonatal hypoglycemia Neonatal jaundice Shoulder dystocia Obstetric brachial plexus injury
Economic evaluation12 weeks up to 18 monthsData on health care utilization for women Data on health care utilization for children
Provider experience of LCG12 weeks up to 18 monthsinterviews
Obstetric outcomes12 weeks up to 18 monthsRates of spontaneous vaginal delivery Rates of instrumental delivery Indications for intrapartum cesarean section Rates of oxytocin use for augmentation of labor Cervical dilation at onset of augmentation (centimeters) Rates of adherence to oxytocin use recommendations Rates of epidural use Amount of postpartum bleeding, ml Rates of perineal laceration (grade II-IV) Duration of labor, minutes

Countries

Sweden

Contacts

Primary ContactMarie Blomberg, Professor
marie.blomberg@liu.se+4613288956
Backup ContactAnna Ramö Isgren, pHD
anna.ramo.isgren@regionostergotland.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026